Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crovalimab vs Eculizumab in PNH Patients Currently Treated With Complement Inhibitors
NCT04432584Phase 3Active, not recruiting
- Sponsor
- Roche
- Start
- Sep 2020
- Primary completion
- Apr 2027
- Modality
- Monoclonal Antibodies
- Countries
- 24
01
Overview
A Phase 3 trial of crovalimab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Roche. Started Sep 2020; status: active, not recruiting.
02
Drugs
crovalimab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT04432584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432584.